Genetic variants associated with major depressive disorder have been identified

July 16, 2015 by Bob Yirka, Medical Xpress report
Credit: George Hodan/Public Domain

(Medical Xpress)—A very large team of researchers made up mostly of members in China and calling itself the CONVERGE consortium, has identified two genetic variants that appear to be associated with major depressive disorder (MDD). In their paper published in the journal Nature, the team explains how they conducted their research, the results they found, and what their findings might mean for treating people with the disorder. Patrick Sullivan, with the University of North Carolina offers a News & Views piece on the work done by the team in the same journal issue.

MDD is a uniquely difficult problem—patients report mostly similar symptoms, such as feelings of sadness, lack of emotions all together and lethargy, but science has not been able to find its cause, much less find a cure. One area of study has been genetics, as scientists wonder if perhaps some people are more susceptible due to DNA passed down from their parents. Unfortunately, despite several studies, no genetic link has been found—until now. In this new effort, the team reports that they have found two genetic variants that appear to be tied to people with the most severe form of MDD.

Because of failures in other genetic studies, the researchers with this new effort chose to go a different route; first they started by selecting China as the place, because of the large population and because MDD is not often diagnosed there, which they figured meant, those that due get such a diagnosis are likely severe cases. Next, they restricted study cases to just women of Han Chinese ancestry. They also chose to use low-convergence whole genome sequencing.

The team identified two regions in the genome which appeared to be associated with MDD. The first one was near the SIRT1 gene, the other was in an intron region of the LHPP gene. The first region is possibly the most intriguing Sullivan notes, due to its closeness to the SIRT1 gene—it suggests a possible connection with mitochondria, the part of cells involved in energy production. If that turns out to be the case, this discovery could lead to treatments dedicated to reinvigorating cells at their energy centers.

The discovery by the team is truly groundbreaking, though they suggest that a lot more work still needs to be done with MDD in general to truly understand its cause and then to come up with a better way to treat it.

Explore further: Fertility patients' history is best predictor of risk for major depression

More information: "Sparse whole-genome sequencing identifies two loci for major depressive disorder." Nature (2015) DOI: 10.1038/nature14659

Abstract
Major depressive disorder (MDD), one of the most frequently encountered forms of mental illness and a leading cause of disability worldwide1, poses a major challenge to genetic analysis. To date, no robustly replicated genetic loci have been identified2, despite analysis of more than 9,000 cases3. Here, using low-coverage whole-genome sequencing of 5,303 Chinese women with recurrent MDD selected to reduce phenotypic heterogeneity, and 5,337 controls screened to exclude MDD, we identified, and subsequently replicated in an independent sample, two loci contributing to risk of MDD on chromosome 10: one near the SIRT1 gene (P = 2.53 × 10−10), the other in an intron of the LHPP gene (P = 6.45 × 10−12). Analysis of 4,509 cases with a severe subtype of MDD, melancholia, yielded an increased genetic signal at the SIRT1 locus. We attribute our success to the recruitment of relatively homogeneous cases with severe illness.

Press release

Related Stories

Fertility patients' history is best predictor of risk for major depression

April 3, 2015
A potent risk factor for developing major depressive disorder (MDD) during fertility treatment is something health providers are likely not even looking for, according to new research from San Francisco State University.

Recurrent major depressive disorder and use of antidepressants associated with lower bone density

June 12, 2015
A recent study from the University of Eastern Finland in collaboration with Deakin University, Australia, shows that recurrent major depressive disorder (MDD) in men is associated with lower bone density. The use of antidepressants ...

Rural African-American women had lower rates of depression, mood disorder

April 8, 2015
African-American women who live in rural areas have lower rates of major depressive disorder (MDD) and mood disorder compared with their urban counterparts, while rural non-Hispanic white women have higher rates for both ...

Adolescent major depression in the National Comorbidity Survey

January 6, 2015
A recent study published in the January 2015 issue of the Journal of the American Academy of Child and Adolescent Psychiatry underscores the important public health significance of depression among U.S. adolescents.

Researchers build a better mouse model to study depression

May 19, 2011
Researchers at the University of Pittsburgh School of Medicine have developed a mouse model of major depressive disorder (MDD) that is based on a rare genetic mutation that appears to cause MDD in the majority of people who ...

What is the best measure of depression severity in adolescents?

March 30, 2015
At present the key symptom for diagnosing major depressive disorder (MDD) in adolescents is irritability. However a new study has found that the severity of anhedonia (the inability to gain pleasure from experiences that ...

Recommended for you

Critical role of DHA on foetal brain development revealed

August 17, 2018
Duke-NUS researchers have found evidence that a natural form of Docosahexaenoic Acid (DHA) made by the liver called Lyso-Phosphatidyl-Choline (LPC-DHA), is critical for normal foetal and infant brain development, and that ...

New algorithm could improve diagnosis of rare diseases

August 17, 2018
Today, diagnosing rare genetic diseases requires a slow process of educated guesswork. Gill Bejerano, Ph.D., associate professor of developmental biology and of computer science at Stanford, is working to speed it up.

Gene silencing critical for normal breast development

August 17, 2018
Researchers have discovered that normal breast development relies on a genetic 'brake', a protein complex that keeps swathes of genes silenced.

Officials remove special rules for gene therapy experiments

August 16, 2018
U.S. health officials are eliminating special regulations for gene therapy experiments, saying that what was once exotic science is quickly becoming an established form of medical care with no extraordinary risks.

Genetic link discovered between circadian rhythms and mood disorders

August 15, 2018
Circadian rhythms are regular 24-hour variations in behaviour and activity that control many aspects of our lives, from hormone levels to sleeping and eating habits.

Ovarian cancer genetics unravelled

August 14, 2018
Patterns of genetic mutation in ovarian cancer are helping make sense of the disease, and could be used to personalise treatment in future.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.